Rachele Alzani

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer

Andrea Sartore‐Bianchi, Elena Ardini, Roberta Bosotti et al. · JNCI Journal of the National Cancer Institute · 2015 · 245 citations · Full text

Radiation Oncology, Systems Biology, Oncology +15

A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity

Alessia Montagnoli, Barbara Valsasina, Valter Croci et al. · Nature Chemical Biology · 2008 · 213 citations · Full text

Cell Regulation, Medicine, Cdc7 Kinase Inhibitor +7

The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition

Elena Ardini, Roberta Bosotti, Andrea Borgia et al. · Molecular Oncology · 2014 · 151 citations · Full text

Trka Kinase Inhibition, Pathology, Cancer Biology +21

NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies

Barbara Valsasina, Italo Beria, Cristina Alli et al. · Molecular Cancer Therapeutics · 2012 · 119 citations · Full text

Bipolar Spindle Formation, Antitumor Activity, Cell Death +17

3-Aminopyrazole Inhibitors of CDK2/Cyclin A as Antitumor Agents. 2. Lead Optimization

Paolo Pevarello, Maria Gabriella Brasca, Paolo Orsini et al. · Journal of Medicinal Chemistry · 2005 · 107 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Chemical Biology +20